Hexamollamide, a hexapeptide from an Okinawan ascidian Didemnum molle

Toshiaki Teruya, Hiroaki Sasaki, Kiyotake Suenaga

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

The bioassay-guided fractionation of the cytotoxic constituents of the Okinawan ascidian Didemnum molle led to the isolation of hexamollamide (1), a hexapeptide. The gross structure and relative stereostructure of 1 were established by spectroscopic analysis including 2D NMR techniques and single-crystal X-ray diffraction analysis. The absolute stereostructure was determined by chiral HPLC analysis of acid hydrolysates of 1. Hexamollamide (1) exhibits moderate cytotoxicity against HeLa S3 cells.

Original languageEnglish
Pages (from-to)5297-5299
Number of pages3
JournalTetrahedron Letters
Volume49
Issue number36
DOIs
Publication statusPublished - 2008 Sep 1

ASJC Scopus subject areas

  • Biochemistry
  • Drug Discovery
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Hexamollamide, a hexapeptide from an Okinawan ascidian Didemnum molle'. Together they form a unique fingerprint.

Cite this